Eric D. Shaff - Net Worth and Insider Trading
Eric D. Shaff Net Worth
The estimated net worth of Eric D. Shaff is at least $130,779 dollars as of 2024-05-28. Eric D. Shaff is the CEO and President of Seres Therapeutics Inc and owns about 140,698 shares of Seres Therapeutics Inc (MCRB) stock worth over $130,779. Details can be seen in Eric D. Shaff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eric D. Shaff has not made any transactions after 2024-05-15 and currently still holds the listed stock(s).
Transaction Summary of Eric D. Shaff
Eric D. Shaff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric D. Shaff owns 2 companies in total, including Seres Therapeutics Inc (MCRB) , and Sigilon Therapeutics Inc (SGTX) .
Click here to see the complete history of Eric D. Shaff’s form 4 insider trades.
Insider Ownership Summary of Eric D. Shaff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2024-05-15 | CFO and EVP |
| SGTX | Sigilon Therapeutics Inc | 2020-12-03 | director |
Eric D. Shaff Latest Holdings Summary
Eric D. Shaff currently owns a total of 1 stock. Eric D. Shaff owns 140,698 shares of Seres Therapeutics Inc (MCRB) as of May 15, 2024, with a value of $130,779.
Latest Holdings of Eric D. Shaff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2024-05-15 | 140,698 | 0.93 | 130,779 |
Holding Weightings of Eric D. Shaff
Eric D. Shaff Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric D. Shaff has made a total of 3 transactions in Seres Therapeutics Inc (MCRB) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Seres Therapeutics Inc is the sale of 2,435 shares on May 15, 2024, which brought Eric D. Shaff around $2,289.
Insider Trading History of Eric D. Shaff
- 1
Eric D. Shaff Trading Performance
Eric D. Shaff Ownership Network
Eric D. Shaff Owned Company Details
What does Seres Therapeutics Inc do?
Who are the key executives at Seres Therapeutics Inc?
Eric D. Shaff is the CFO and EVP of Seres Therapeutics Inc. Other key executives at Seres Therapeutics Inc include Chief Scientific Officer Matthew R. Henn , See Remarks Thomas Desrosier , and See Remarks Moltke Lisa Von .
Seres Therapeutics Inc (MCRB) Insider Trades Summary
Over the past 18 months, Eric D. Shaff made 3 insider transaction in Seres Therapeutics Inc (MCRB) with a net sale of 22,536. Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 17,204 shares made by David S. Ege , a net sale of 9,571 shares made by Moltke Lisa Von , and a net sale of 8,947 shares made by Matthew R. Henn .
In summary, during the past 3 months, insiders sold 6,901 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 6,901 shares. During the past 18 months, 85,089 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 85,089 shares.
Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seres Therapeutics Inc Insider Transactions
Eric D. Shaff Mailing Address
Above is the net worth, insider trading, and ownership report for Eric D. Shaff. You might contact Eric D. Shaff via mailing address: C/o Seres Health, Inc., 161 First Street, Cambridge Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
